InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Last Andrew J., Chief Operating Officer. Director active across 5 companies, notably OncoCyte Corp. In total, 19 filings have been published. Split: 1 buy · 1 sell. Total volume traded: €908k. History available since 11 June 2021. The latest transaction was disclosed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Last Andrew J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
7,700 shares@ US$5.69100.0% of flowCommon Stock, no par valueSEC:0001493152-26-032233:0
35,000 shares0Common Stock, no par valueSEC:0001641172-25-017787:0
3,000 shares@ US$299.2428.8% of flowBio-Rad A Common StockSEC:0001062993-24-016386:0
3,000 shares@ US$329.938431.8% of flowBio-Rad A Common StockSEC:0001062993-24-016386:1
1,252 shares0Bio-Rad A Common StockSEC:0001062993-24-016169:0
357 shares@ US$277.113.3% of flowBio-Rad A Common StockSEC:0001062993-24-009082:1
1,000 shares0Bio-Rad A Common StockSEC:0001062993-24-009082:0
867 shares0Bio-Rad A Common StockSEC:0001062993-23-017654:0
20,000 shares0Common Stock, no par valueSEC:0001493152-23-022669:0
1,000 shares0Bio-Rad A Common StockSEC:0001062993-23-009749:0
902 shares0Bio-Rad A Common StockSEC:0001062993-22-019282:0
633 shares0Bio-Rad A Common StockSEC:0001062993-22-019194:0
20,000 shares@ US$0.8733.1% of flowCommon Stock, no par valueSEC:0001493152-22-023524:0
Canonical exit: 15 Nov 2022 (T+90)
10,000 shares0Common Stock, no par valueSEC:0001493152-22-023385:0
10,000 shares0Common Stock, no par valueSEC:0001493152-22-019822:0
1,000 shares0Bio-Rad A Common StockSEC:0001062993-22-011169:0
2,000 shares@ US$299.2422.0% of flowBio-Rad A Common StockSEC:0001062993-21-008244:0
6,993 shares@ US$3.0050.2% of flowCommon StockSEC:0001493152-21-014342:0
37,297 sharesCommon StockSEC:0001140361-16-051546:0
19 of 19 declarations
About Last Andrew J.
Last Andrew J. is Director of Operations. He has 19 filings in total, and across the recent sample of 19 filings, the reported cumulative amounts are EUR 17,092 of buys and EUR 890,834 of sells, with activity ranging from 2016-02-10 to 2026-07-06. The most common transaction nature is Option exercise, and the companies listed are Bio-Rad Laboratories, INC., OncoCyte Corp, Insight Molecular Diagnostics Inc., and AFFYMETRIX INC.
